Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by total assets, at SGD 196.8M, followed by Erasca (SGD 510.9M) and Definium Therapeutics (SGD 567.6M). Figures as of 18 Nov 2026, 19:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSGD 196.8M
- Median
- SGD 4.5B
- Combined market value
- SGD 6.54T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SGD 196.8M | SGD 6.8B | SGD 160.26 | 1.10% down | 233% up | ||
| 2 | ErascaERAS · Health Care | SGD 510.9M | SGD 6B | SGD 17.23 | 3.82% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | SGD 567.6M | SGD 5B | SGD 36.82 | 2.83% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 619.3M | SGD 10.8B | SGD 155.10 | 3.13% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | SGD 630.2M | SGD 8.3B | SGD 122.98 | 1.00% down | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | SGD 684.7M | SGD 6.3B | SGD 111.54 | 0.57% down | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | SGD 712.7M | SGD 5.9B | SGD 53.60 | 1.14% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | SGD 780.5M | SGD 6.3B | SGD 65.43 | 0.72% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | SGD 836.2M | SGD 9.4B | SGD 107.81 | 1.81% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | SGD 861.8M | SGD 10.6B | SGD 161.87 | 0.67% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | SGD 889.7M | SGD 9.1B | SGD 172.38 | 1.69% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | SGD 968.8M | SGD 10.9B | SGD 13.58 | 1.31% down | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 984.9M | SGD 9.6B | SGD 122.64 | 0.02% down | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | SGD 1B | SGD 11.8B | SGD 124.20 | 2.65% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | SGD 1B | SGD 8.2B | SGD 202.11 | 0.64% down | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | SGD 1.1B | SGD 9.6B | SGD 87.43 | 3.25% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | SGD 1.1B | SGD 7.7B | SGD 118.49 | 0.09% down | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | SGD 1.2B | SGD 19.5B | SGD 100.31 | 1.27% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | SGD 1.2B | SGD 6.3B | SGD 36.04 | 0.34% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.2B | SGD 11B | SGD 394.86 | 0.36% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | SGD 1.4B | SGD 12.8B | SGD 84.93 | 5.01% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.6B | SGD 12B | SGD 517.42 | 4.93% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.8B | SGD 7.9B | SGD 55.79 | 0.63% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | SGD 1.8B | SGD 9.2B | SGD 65.88 | 1.10% down | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | SGD 1.9B | SGD 22.9B | SGD 349.23 | 0.15% down | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | SGD 2B | SGD 7.8B | SGD 387.89 | 2.36% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | SGD 2.2B | SGD 4B | SGD 20.84 | 0.31% up | 42% down | ||
| 28 | InsmedINSM · Health Care | SGD 2.9B | SGD 34B | SGD 155.16 | 1.28% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | SGD 3.2B | SGD 10.1B | SGD 60.06 | 2.46% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SGD 3.7B | SGD 6.5B | SGD 77.61 | 0.31% down | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | SGD 4.5B | SGD 6B | SGD 35.87 | 3.15% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.9B | SGD 28.34 | 4.05% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | SGD 6.4B | SGD 25.8B | SGD 192.43 | 4.66% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | SGD 7.4B | SGD 35.9B | SGD 49.50 | 0.85% down | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 8B | SGD 16.2B | SGD 19.39 | 1.66% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | SGD 9.8B | SGD 15.2B | SGD 78.40 | 3.90% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | SGD 10.2B | SGD 31.9B | SGD 749.60 | 0.49% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | SGD 10.6B | SGD 59.5B | SGD 521.23 | 2.21% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 15B | SGD 20.4B | SGD 317.54 | 2.28% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | SGD 16.6B | SGD 40.8B | SGD 66.18 | 1.25% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | SGD 17.2B | SGD 17.3B | SGD 34.71 | 4.10% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | SGD 19.9B | SGD 44.8B | SGD 110.27 | 2.42% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | SGD 25.3B | SGD 51.4B | SGD 89.40 | 0.92% up | 78% up | ||
| 44 | GrifolsGRFS · Health Care | SGD 28.2B | SGD 7.4B | SGD 10.87 | 2.38% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | SGD 33.1B | SGD 175.9B | SGD 693.94 | 0.72% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | SGD 48B | SGD 30.5B | SGD 26.59 | 0.81% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | SGD 52.3B | SGD 126.1B | SGD 1,219.07 | 1.31% down | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 52.6B | SGD 63.3B | SGD 54.25 | 1.30% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | SGD 103.9B | SGD 224.7B | SGD 50.98 | 2.89% down | 17% down | ||
| 50 | GSKGSK · Health Care | SGD 104.6B | SGD 125.8B | SGD 62.76 | 1.18% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | SGD 111.8B | SGD 233.4B | SGD 134.76 | 0.21% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | SGD 116.1B | SGD 158B | SGD 77.28 | 2.33% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | SGD 125.3B | SGD 87.9B | SGD 27.52 | 1.39% down | 54% up | ||
| 54 | NovartisNVS · Health Care | SGD 143.1B | SGD 379B | SGD 200.65 | 2.23% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | SGD 145.1B | SGD 1.6T | SGD 1,791.37 | 1.88% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | SGD 147.1B | SGD 358B | SGD 230.80 | 1.82% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | SGD 172.8B | SGD 654B | SGD 370.00 | 2.03% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | SGD 176.5B | SGD 438.1B | SGD 177.72 | 3.89% down | 51% up | ||
| 59 | SanofiSNY · Health Care | SGD 181.5B | SGD 146.4B | SGD 60.95 | 0.57% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | SGD 256.9B | SGD 851.6B | SGD 353.74 | 1.59% down | 38% up | ||
| 61 | PfizerPFE · Health Care | SGD 268.5B | SGD 206.5B | SGD 36.22 | 1.35% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2897 SGD).
Questions and answers
Which pharmaceutical companies have the lowest total assets?
Veradermics (SGD 196.8M), Erasca (SGD 510.9M) and Definium Therapeutics (SGD 567.6M) have the lowest total assets of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 19:11 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of SGD 6.54T as of 18 Nov 2026, 19:11 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.